Departments, Centers, & Programs:
Zero Emerson Place
Boston, MA 02114-2696
- MPH, Harvard T. H. Chan School of Public Health
- MD, Johns Hopkins University School of Medicine
- Residency, Brigham and Women's Hospital
American Board Certifications
- Emergency Medicine, American Board of Emergency Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Kabrhel's research is focused on the epidemiology, diagnosis, risk-stratification, treatment, and health policy aspects of PE and DVT. His work is funded by the NIH (R01, R21, STTR), private foundations, and industry partners. When his research into VTE began, about 15 years ago, he concentrated on topics relevant to emergency medicine and related specialties. However, over the past decade his research has expanded into areas interesting to the scientific community at large. These include multicenter clinical trials and biomarker studies, but also VTE genetics, economics, environmental epidemiology, metabolomics, and nutrition.
In addition to clinical research, Dr. Kabrhel coordinates PE research for the two Nurses’ Health Studies (Channing Network Medicine at BWH) and Health Professionals Follow Up Study (HSPH). His early work with these cohorts was funded by an R21 from the National Heart, Lung and Blood Institute and the National Institute for Aging and resulted in several publications describing novel environmental risk factors for VTE. In 2012, he was awarded NIH/NHLBI funding (R01) to study novel genetic and environmental risk factors for VTE. As part of this grant, he co-founded the International Network for VENous Thromboembolism (INVENT) Consortium, an international collaboration focused on discovering novel genetic and epidemiological risk factors for VTE. More recently, he performed the first metabolomic studies to identify metabolites and metabolic profiles associated with VTE.